ArticleScientific reports2026
A general model for determination of molecular structures of anti-biofilm compounds through metric-based resolvability.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Based on distance measures descriptors can indeed provide useful information about structural aspects of a molecule by providing a unique identification of atoms for a particular molecular graph. A set of vertices that allows the atoms of a graph to be uniquely identified based on their distances to the set is called a resolving set, whereas the smallest such set is called the metric dimension of the graph. In this research work, we discuss the metric dimension of the molecular graph of some of the most influential anti-biofilm agents such as chlorhexidine, colistin, berberine, usnic acid, ellagic acid, curcumin, and epigallocatechin gallate. The obtained results show that metric dimension distinguishes these compounds according to their topological complexity, degree of branching, and structural repetition, and therefore provides a useful distance-based descriptor for molecular characterization and graph-based identification of anti-biofilm agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.